Avanos Medical (AVNS) Accumulated Expenses (2013 - 2026)

Avanos Medical has reported Accumulated Expenses for 14 years, with the latest figure at $57.6 million in Q1 2026.

• Quarterly Accumulated Expenses fell 19.33% year-over-year to $57.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $57.6 million (down 19.33% YoY) and the FY2025 annual result came in at $91.3 million, changed 0.0% from the prior year.
• Accumulated Expenses slipped to $57.6 million in Q1 2026 per AVNS's latest filing, from $91.3 million in the prior quarter.
• Over five years, Accumulated Expenses peaked at $97.8 million in Q4 2022 and troughed at $57.6 million in Q1 2026.
• A 5-year average of $79.7 million and a median of $79.5 million in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2026: Accumulated Expenses soared 43.61% in 2022, then retreated 19.33% in 2026.
• Over 5 years, Accumulated Expenses stood at $97.8 million in 2022, then declined by 4.7% to $93.2 million in 2023, then declined by 2.04% to $91.3 million in 2024, then changed by 0.0% to $91.3 million in 2025, then slumped by 36.91% to $57.6 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $57.6 million, $91.3 million, and $74.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.